Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin

MeSH terms

• Adult
• Anti-Bacterial Agents / adverse effects*
• Anti-Bacterial Agents / chemistry
• Anti-Bacterial Agents / therapeutic use
• Antifungal Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Antiviral Agents / therapeutic use
• Bicarbonates / adverse effects
• Bicarbonates / therapeutic use
• Bleomycin / administration & dosage
• Ciprofloxacin / adverse effects*
• Ciprofloxacin / chemistry
• Ciprofloxacin / therapeutic use
• Crystallization
• Cyclophosphamide / administration & dosage
• Cytarabine / administration & dosage
• Diarrhea / chemically induced
• Doxorubicin / administration & dosage
• Drug Eruptions / etiology*
• Drug Interactions
• Etoposide / administration & dosage
• Female
• Fluid Therapy
• Fungemia / complications
• Fungemia / drug therapy
• Humans
• Hydrogen-Ion Concentration
• Ifosfamide / administration & dosage
• Lymphoma, B-Cell / drug therapy
• Mediastinal Neoplasms / drug therapy
• Metabolic Clearance Rate / drug effects
• Methotrexate / administration & dosage
• Methotrexate / adverse effects*
• Methotrexate / blood
• Methotrexate / pharmacokinetics
• Mucositis / chemically induced*
• Pancytopenia / chemically induced*
• Prednisone / administration & dosage
• Solubility
• Urine / chemistry
• Vindesine / administration & dosage